The importance of prompt empiric therapy is clear: it leads to better survival among patients with both community- and hospital-acquired infections. Tools such as antibiograms are used to help guide antibiotic selection. However, broad-based antibiograms may not always be appropriate for all areas of an institution.
The importance of prompt empiric therapy is clear. Prompt empiric therapy leads to better survival among patients with both community- and hospital-acquired infections.
Citing a paper by Luna et al, Laurimay Larocco, PharmD, with WakeMed Health and Hospitals in Raleigh, North Carolina, impressed upon the audience that initial therapy with inadequate antimicrobials might lead to higher mortality rates and adverse clinical outcomes.
Dr Larocco explained that although empiric antibiotic therapy does not have the benefit of selection based on actual cultures, other factors may inform the decision of which antimicrobial to use. For instance, patient age, organ dysfunction (ie, kidney, liver), and pharmacokinetic factors may play a role in the selection. Additionally, the antibiogram for a given hospital may recommend use of one antibiotic over another.
Although hospitals use an overall antibiogram, Dr Larocco differentiated hospital antibiograms from unit-specific documentation of susceptibility. The benefits of a unit-specific antibiogram have been supported by several studies. Bryce and Smith compared the antibiotic susceptibility of isolates of Pseudomonas aerugenosa in the intensive-care unit (ICU) setting to isolates found in other parts of the same hospital and found a higher resistance rate in the ICU than elsewhere, which were reflected in 2 additional studies presented.
Offering a possible explanation for these findings, Dr Larocco emphasized that patients in a higher age range with more disabling conditions, higher prevalence of prior antibiotic use, and more implanted medical devices are at a higher risk for antibiotic resistance. Showing data that demonstrated the higher rate of long-term care residence, dialysis use, HIV infection, and a primary diagnosis of an infection, she explained that patients treated in the emergency department (ED) may be more prone to infection with isolates of bacteria that are resistant to antibiotic treatment. As a result, the importance of a separate antibiogram for this group to optimize outcomes can be visualized.
Using the case of a skin infection to demonstrate the difference between infections obtained in the hospital setting and infections from the community setting, Dr Larocco showed that clindamycin effectively treated skin infections in 67% of cases of hospital-acquired infections versus 90% of community-acquired infections. Similarly, higher cure rates were observed for skin infections acquired in the community setting with 2 other antibiotics.
Some challenges to developing a hospital-specific antibiogram include the lack of entries for the site of collection of blood and urine samples. This lack of information poses a serious challenge to retrospective collection of data for development of an antibiogram. However, minor changes to information technology might facilitate development of an ED-specific antibiogram.
The resulting susceptibility information might have several benefits, as described by Dr Larocco, including more timely selection of empiric antibiotic treatment, greater comfort with antibiotic selection among caregivers, and fewer escalations of therapy. To achieve these benefits, multidisciplinary support from pharmacy staff, laboratory technicians, and physicians is important. Additionally, once developed, the antibiogram would need to be embedded into prescribing software used in the ED.
Dr Larocco emphasized the differences between microbial isolate resistance patterns to antibiotics between patients in the overall hospital population versus those treated in the ED setting. The differences between these groups, apparent from multiple studies, might lead to clinically significant differences in which empiric antimicrobial therapies are most appropriate for treatment of common infections. Establishing an antibiogram might improve therapeutic outcomes for patients and increase the comfort level of prescribers and pharmacists with the choice of antibiotic therapy.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More